rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2-3
|
pubmed:dateCreated |
1999-2-9
|
pubmed:abstractText |
The potential new iron-chelator cytisine and the radical scavenger N-tert-butyl-alpha-(2-sulfophenyl) nitrone (S-PBN) were incubated in a Fenton system and hydroxyl radical formation was measured with the salicylate trapping assay. Both cytisine and S-PBN reduced hydroxyl radical formation in a concentration-dependent manner. For in vivo studies, C57BL/6 mice were injected repeatedly with cytisine (0.5 mg/kg or 2.0 mg/kg s.c.) or saline seven days before and after a single 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) injection (30 mg/kg s.c.). Seven days after MPTP treatment alone dopamine levels were significantly reduced to 12% of the control values (p < 0.001), whereas MPTP + cytisine treatment (2 mg/kg) led to more than twofold higher dopamine levels (p < 0.01) compared with MPTP alone. We have shown for the first time that cytisine attenuates hydroxyl radical formation in vitro and reduces MPTP-induced dopamine depletion. Thus, cytisine may be useful for the treatment of Parkinson's Disease where the chelation of iron ions could prevent neuronal cell death.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-Methyl-4-phenyl-1,2,3,6-tetrahydro...,
http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids,
http://linkedlifedata.com/resource/pubmed/chemical/Azocines,
http://linkedlifedata.com/resource/pubmed/chemical/Benzenesulfonates,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyl Radical,
http://linkedlifedata.com/resource/pubmed/chemical/N-tert-butyl-(2-sulfophenyl)nitrone,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolizines,
http://linkedlifedata.com/resource/pubmed/chemical/cytisine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0014-2999
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
360
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
155-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9851582-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
pubmed-meshheading:9851582-Alkaloids,
pubmed-meshheading:9851582-Animals,
pubmed-meshheading:9851582-Azocines,
pubmed-meshheading:9851582-Benzenesulfonates,
pubmed-meshheading:9851582-Dopamine,
pubmed-meshheading:9851582-Dopamine Agents,
pubmed-meshheading:9851582-Hydroxyl Radical,
pubmed-meshheading:9851582-Male,
pubmed-meshheading:9851582-Mice,
pubmed-meshheading:9851582-Mice, Inbred C57BL,
pubmed-meshheading:9851582-Motor Activity,
pubmed-meshheading:9851582-Nerve Degeneration,
pubmed-meshheading:9851582-Neurons,
pubmed-meshheading:9851582-Neuroprotective Agents,
pubmed-meshheading:9851582-Quinolizines
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo.
|
pubmed:affiliation |
Institute of Pharmacology and Toxicology, Faculty of Pharmacy, University of Marburg, Germany. ferger@mailer.uni-marburg.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|